Moclobemide in the treatment of depressive syndrome in schizophrenia

Author： Jasovic-Gasic M.   Nikolic-Balkoski G.   Totic S.   Acimovic B.   Kuzmanovic V.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 297-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Citalopram/moclobemide/sertraline overdose: Serotonin syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1172, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Treatment of severe recurrent major depression: comparative efficacy and tolerability of moclobemide and impiramine

By Hochstrasser B.   Ferrero F.   Gachoud J.-P.   Gasser U.E.   Mascetti R.   Meyer J.W.   Wacker H.R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 298-298

Elsevier

Access to resources Recommend Favorite

Common Treatment of Polycystic Ovarian Syndrome and Major Depressive Disorder: Case Report and Review

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 97-102

Bentham Science Publishers

Access to resources Recommend Favorite

Co-Occurring Depressive Symptoms in the Older Patient with Schizophrenia

By Kasckow John W.   Zisook Sidney  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 631-647

Adis International

Access to resources Recommend Favorite

Moclobemide/venlafaxine overdose, interaction: Fatal serotonin syndrome in a cocaine addict: case report

By  

Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite